$GEVO

Agiri Oluwagbemileke Yusuf sold $88K of GEVO

Agiri Oluwagbemileke Yusuf (CFO) sold 63,028 shares of Gevo, Inc. (GEVO) at $1.40 on 2026-06-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Agiri Oluwagbemileke Yusuf
Published Jun 15, 2026, 9:22 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 15, 2026, 9:25 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$GEVO
Neutral
high confidence
Mentioned
$GEVO
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GEVONeutralLow
01

Why it matters

The newest fact is the CFO’s open-market sale details (shares, price, total value) and that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

This provides a concrete insider ownership change, but the 10b5-1 structure makes it less likely to be a strong fundamental catalyst.

03

What to watch

Traders may want to compare this sale size versus prior Form 4 activity and check whether other insiders or large holders are also transacting around the same window.

Relevance 2/10Novelty 5/10Timing: Filed June 15; sale executed June 12

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for Gevo, Inc.

Company-level read

Ticker impact

$GEVONeutralHigh confidence
Context

Gevo CFO Agiri Oluwagbemileke Yusuf filed an SEC Form 4 selling 63,028 shares at $1.3974 on a 10b5-1 plan.

Expected impact

Likely minimal immediate price impact; any effect would be sentiment-driven and short-lived.

Evidence & confidence

The disclosure is a Form 4 insider sale with explicit 10b5-1 pre-arrangement, which typically reduces interpretive weight versus discretionary selling.

Market effects

No sector-level read-across; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider sales can still coincide with management’s view of near-term valuation risk.

Key entities

  • Gevo, Inc.

    Company whose CFO filed the Form 4 insider sale disclosure.

  • Agiri Oluwagbemileke Yusuf

    Gevo CFO who sold 63,028 shares at $1.3974 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$GEVOMedAI 8/10

Gevo (GEVO) Q2 2026 Earnings Call Transcript

Gevo (GEVO) reported Q2 2026 revenue of $47 million, up 7% year over year, and non-GAAP adjusted EBITDA of $11 million. Full-year 2026 adjusted EBITDA guidance is now above $60 million. The company targets $70 million of 45Z tax credit monetization in 2026 and recorded a $176 million noncash impairment tied to exiting its ATJ-60 project.

$GEVOHigh

Gevo, Inc. (GEVO): Results of Operations and Financial Condition

Gevo, Inc. (GEVO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Gevo Reports Second Quarter Results and Raises Financial Expectations for Full-Year 2026 ENGLEWOOD, Colo. – August 6, 2026 – Gevo, Inc. (NASDAQ: GEVO), a leader in renewable fuels, chemicals and carbon management, today announced its financial results for the second

$GEVOMedAI 8/10

Why Is Gevo (GEVO) Stock Rocketing Higher Today

Gevo (NASDAQ: GEVO) shares rose about 7.5% after the company said it expects 2026 non-GAAP Adjusted EBITDA to be more than double prior estimates. Gevo attributed the upgrade to new carbon pathways, higher production, and cost reductions, and it announced Todd Werpy, Ph.D., joining its board. The stock is volatile and trades at $1.68.